Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.

Pastor, MyriamRamos González, Ana MaríaFernández Calle, RosalíaCoderch Boué, ClaireDi Geronimo Quintero, BrunoVicente Rodríguez, MartaPascual-Teresa Fernández, Beatriz deZapico Rodríguez, José MaríaLasek, Amy W.Pineda-Lucena, AntonioGramage, EstherHerradón Gil-Gallardo, GonzaloPérez García, Carmen2018-11-142018-11-142018-01-20Pastor M, Fernández-Calle R, Di Geronimo B, Vicente-Rodríguez M, Zapico JM, Gramage E, et al. Development of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders. Vol. 144, European Journal of Medicinal Chemistry. 2018. p. 318-290223-5234http://hdl.handle.net/10637/9746application/pdfenopen accessPTPRZ1inhibitorsPleiotrophinNeurogenerative diseasesDevelopment of inhibitors of receptor protein tyrosine phosphatase β/ζ (PTPRZ1) as candidates for CNS disorders.Artículo10.1016/j.ejmech.2017.11.080https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es